EglN2 associates with the NRF1‐PGC1α complex and controls mitochondrial function in breast cancer
Jing Zhang(Jiangxi University of Traditional Chinese Medicine), Qing Zhang(Southwestern Medical Center), Xingnan Zheng(University of North Carolina at Chapel Hill), Haitao Wen(The Ohio State University), Xiaole Shirley Liu(Dana-Farber Cancer Institute), Katherine M. Aird(The Wistar Institute), Mamoru Takada(University of North Carolina at Chapel Hill), William G. Kaelin(Broad Institute), Chenguang Wang(North University of China), Xi Chen(Baylor College of Medicine), Yong Liu(Chinese Academy of Sciences), Richard G. Pestell(Baruch S. Blumberg Institute), Cheng Fan(University of North Carolina at Chapel Hill), Chengyang Wang(Tongji University)
Cited by 72
Related Papers
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k
Identifying ChIP-seq enrichment using MACS
|Nature Protocols|2012|2.1k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k